A Pilot Study for Discovering Candidate Genes of Chromosome 18q21 in Methamphetamine Abusers: Case-control Association Study

키워드

참고문헌 (70)

1. McGuffin P, "The strength of the genetic effect. Is there room for an environmental influence in the aetiology of schizophrenia?", Br J Psychiatry, 164, pp.593~599 (1994)
2. Bachmann RF, "Mood stabilizers target cellular plasticity and resilience cascades:implications for the development of novel therapeutics", Mol Neurobiol, 32, pp.173~202 (2005)
3. Bauer M, "Lawson WB; NIMH Affective Disorders Workgroup. Bipolar disorder", Ment Health Serv Res, 4, pp.225~229 (2002)
4. Bartels SJ, "Medicare and medicaid costs for schizophrenia patients by age cohort compared with costs for depression, dementia, and medically ill patients", Am J Geriatr Psychiatry, 11, pp.648~657 (2003)
5. Chung H, "Recent trends of drug abuse and drug-associated deaths in Korea", Ann N Y Acad Sci, 1025, pp.458~464 (2004)
6. McKetin R, "The rise of methamphetamine in Southeast and East Asia", Drug Alcohol Rev, 27, pp.220~228 (2008)
7. Kulsudjarit K., "Drug problem in southeast and southwest Asia", Ann N Y Acad Sci, 1025, pp.446~457 (2004)
8. Rawson RA, "Why do we need an Addiction supplement focused on methamphetamine?", Addiction, 102(Suppl 1), pp.1~4 (2007)
9. Lapworth K, "Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users", Addict Behav, 34, pp.380~385 (2009)
10. Dore G, "Drug-induced psychosis associated with crystalline methamphetamine", Australas Psychiatry, 14, pp.86~89 (2006)
11. Zweben JE, "Methamphetamine Treatment Project. Psychiatric symptoms in methamphetamine users", Am J Addict, 13, pp.181~190 (2004)
12. Buffenstein A, "Chronic psychotic illness from methamphetamine", Am J Psychiatry, 156, pp.662~ (1999)
13. Murray JB., "Psychophysiological aspects of amphetaminemethamphetamine abuse", J Psychol, 132, pp.227~237 (1998)
14. Shih RA, "A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders", Int Rev Psychiatry, 16, pp.260~283 (2004)
15. Van Broeckhoven C, "Report of the chromosome 18 workshop", Am J Med Genet, 88, pp.263~270 (1999)
16. Pulver AE, "Genetic heterogeneity in schizophrenia:stratification of genome scan data using co-segregating related phenotypes", . Mol Psychiatry, 5, pp.650~653 (2000)
17. Siris SG., "Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents", Am J Psychiatry, 157, pp.1379~1389 (2000)
18. Bailer U, "Genome scan for susceptibility loci for schizophrenia and bipolar disorder", Biol Psychiatry, 52, pp.40~52 (2002)
19. Cardno AG, "A twin study of genetic relationships between psychotic symptoms", Am J Psychiatry, 159, pp.539~545 (2002)
20. Potash JB, "Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder", Am J Psychiatry, 160, pp.680~686 (2003)
21. Berrettini W., "Bipolar disorder and schizophrenia: convergent molecular data", Neuromolecular Med, 5, pp.109~117 (2004)
22. Walss-Bass C, "Evidence of genetic overlap of schizophrenia and bipolar disorder: linkage disequilibrium analysis of chromosome 18 in the Costa Rican population.", Am J Med Genet B Neuropsychiatr Genet, 139B, pp.54~60 (2005)
23. Escamilla M, "The epsin 4 gene is associated with psychotic disorders in families of Latin American origin", Schizophr Res, 106, pp.253~257 (2008)
24. Escamilla MA., "Population isolates: their special value for locating genes for bipolar disorder", Bipolar Disord, 3, pp.299~317 (2001)
25. Tsuang MT, "Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs", Am J Med Genet, 67, pp.473~477 (1996)
26. Kim EY, "Frequency of osteoporosis in 46 men with methamphetamine abuse hospitalized in a National Hospital.", Forensic Sci Int, 188, pp.75~80 (2009)
27. Lee BD, "Malic enzyme 2 and susceptibility to psychosis and mania", Psychiatry Res, 150, pp.1~11 (2007)
28. Broman KW, "Comprehensive human genetic maps: individual and sex-specific variation in recombination", Am J Hum Genet, 63, pp.861~869 (1998)
29. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" (1994), American Psychiatric Press
30. Hassel B., "Pyruvate carboxylation in neurons", J Neurosci Res, 66, pp.755~762 (2001)
31. Uhl GR, ""Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice", Biochem Pharmacol, 75, pp.98~111 (2008)
32. Nurnberger JI Jr, "Diagnostic interview for genetic studies. Rationale, unique features, and training", NIMH Genetics Initiative. Arch Gen Psychiatry, 51, pp.849~859 (1994)
33. Tuck SP, "Osteoporosis in the aging male:treatment options", Clin Interv Aging, 2, pp.521~536 (2007)
34. Krum SA, "Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival", EMBO J, 27, pp.535~545 (2008)
35. Yaegashi Y, "Association of hip fracture incidence and intake of calcium, magnesium, vitamin D, and vitamin K", Eur J Epidemiol, 23, pp.219~225 (2008)
36. Mazziotti G, "Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects", Arq Bras Endocrinol Metabol, 51, pp.1404~1412 (2007)
37. Blahos J., "Treatment and prevention of osteoporosis", Wien Med Wochenschr, 157, pp.589~592 (2007)
38. Migliaccio S, "Glucocorticoid-induced osteoporosis: an osteoblastic disease", Aging Clin Exp Res, 19(3 Suppl), pp.5~10 (2007)
39. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" (1996), American Psychiatric Association
40. Weber JL, "Mutation of human short tandem repeats", Hum Mol Genet, 2, pp.1123~1128 (1993)
41. Weir BS., "Genetic Data Analysis II: Methods for discrete population genetic data" (1996), Sinauer Associates
42. Draăghici S., "Data analysis tools for DNA microarrays", pp.2003, Chapman & Hall
43. "Census of the Korean population by administrative distinct, sex and age" (2004)[URL]
44. Maurer I, "Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia", Schizophr Res, 48, pp.125~136 (2001)
45. Middleton FA, "Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia", J Neurosci, 22, pp.2718~2729 (2002)
46. Bubber P, "Mitochondrial enzymes in schizophrenia", J Mol Neurosci, 24, pp.315~321 (2004)
47. Konradi C, "Molecular evidence for mitochondrial dysfunction in bipolar disorder", Arch Gen Psychiatry, 61, pp.300~308 (2004)
48. Prabakaran S, "Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress", Mol Psychiatry, 9, pp.684~697 (2004)
49. Iwamoto K, "Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis", Hum Mol Genet, 14, pp.241~253 (2005)
50. Escamilla MA, "Genome screening for linkage disequilibrium in a Costa Rican sample of patients with bipolar-I disorder: a follow-up study on chromosome 18", Am J Med Genet, 105, pp.207~213 (2001)
51. Williams NM, "A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs", Hum Mol Genet, 8, pp.1729~1739 (1999)
52. Ewald H, "Susceptibility loci for bipolar affective disorder on chromosome 18? A review and a study of Danish families", Psychiatr Genet, 7, pp.1~12 (1997)
53. Maziade M, "A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes", Mol Psychiatry, 6, pp.684~693 (2001)
54. Ohki I, "Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA", Cell, 105, pp.487~497 (2001)
55. Carney RM, "Identification of MeCP2mutations in a series of females with autistic disorder", Pediatr Neurol, 28, pp.205~211 (2003)
56. Greenberg DA, "Malic enzyme 2 may underlie susceptibility to adolescent-onset idiopathic generalized epilepsy.", Am J Hum Genet, 76, pp.139~146 (2005)
57. Itoh S, "Signaling of transforming growth factor-beta family members through Smad proteins", Eur J Biochem, 267, pp.6954~6967 (2000)
58. Lu J, "SMAD pathway mediation of BDNF and TGF beta 2 regulation of proliferation and differentiation of hippocampal granule neurons", Development, 132, pp.3231~3242 (2005)
59. Gonzalez FA, "Heterogeneous expression of four MAP kinase isoforms in human tissues", FEBS Lett, 304, pp.170~178 (1992)
60. Boulton TG, "ERKs: a family of protein-serine", threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF, 1991, pp.65, 663~675
61. Li L, "Genomic loci of human mitogen-activated protein kinases", Oncogene, 9, pp.647~649 (1994)
62. García JI, "Isolation of a cDNA encoding the rat MAP-kinase homolog of human p63mapk", Mamm Genome, 7, pp.810~814 (1996)
63. New L, "PRAK, a novel protein kinase regulated by the p38 MAP kinase", EMBO J, 17, pp.3372~3384 (1998)
64. Ni H, "MAPKAPK5, a novel mitogen-activated protein kinase (MAPK)-activated protein kinase, is a substrate of the extracellular-regulated kinase (ERK) and p38 kinase", Biochem Biophys Res Commun, 243, pp.492~496 (1998)
65. Roux PP, "ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions", Microbiol Mol Biol Rev, 68, pp.320~344 (2004)
66. Gaestel M., "MAPKAP kinases- MKs -two's company, three's a crowd", Nat Rev Mol Cell Biol, 7, pp.120~130 (2006)
67. Schumacher S, "Scaffolding by ERK3 regulates MK5 in development", EMBO J, 23, pp.4770~4779 (2004)
68. Seternes OM, "Activation of MK5", PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway, 2004, pp.23, 4780~4791
69. Liu QR, "Addiction molecular genetics: 639,401 SNP whole genome association identifies many "cell adhesion" genes", Am J Med Genet B Neuropsychiatr Genet, 141B, pp.918~925 (2006)
70. Straub RE, "Susceptibility genes for nicotine dependence: a genome scan and followup in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 18 merit further study", Mol Psychiatry, 4, pp.129~144 (1999)

관련 논문AI추천